# @pennmedicine on Instagram

- **Type:** Video
- **Original URL:** https://www.instagram.com/p/DAWnEcaN-m1
- **Gondola URL:** https://gondola.cc/posts/23537365-pennmedicine-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/thumbnails/86af3d0017.jpg
- **Posted:** 2024-09-25T20:19:50.000+00:00
- **Account Owner:** Penn Medicine (@PennMedicine) — https://gondola.cc/PennMedicine

## Caption

With last year's FDA-approval of #lecanemab, the first drug to slow the progression of #Alzheimers, the field of dementia research has never been more promising. Dr. Jason Karlawish, co-director of the Penn Memory Center, explains other new technologies being developed at Penn Medicine that are contributing to the "biomarker revolution".

#dementia #dementiaresearch

## Stats

- **Views:** 1,523
- **Likes:** 178
- **Shares:** 0
- **Comments:** 2

## Tags

lecanemab, alzheimers, dementia, dementiaresearch

---
Copyright (c) Gondola